These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17469095)

  • 21. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular outcomes in systemic lupus erythematosus: big studies for big questions.
    Haque S; Bruce IN
    J Rheumatol; 2009 Mar; 36(3):467-9. PubMed ID: 19286857
    [No Abstract]   [Full Text] [Related]  

  • 23. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience.
    Abu-Shakra M; Codish S; Zeller L; Wolak T; Sukenik S
    Isr Med Assoc J; 2008 Jan; 10(1):43-4. PubMed ID: 18300571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive strategies in systemic lupus erythematosus.
    Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P
    Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic lupus erythematosus and "lupus dyslipoproteinemia".
    de Carvalho JF; Bonfá E; Borba EF
    Autoimmun Rev; 2008 Jan; 7(3):246-50. PubMed ID: 18190886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematosus.
    Kassaian SE; Goodarzynejad H; Darabian S; Basiri Z
    Cardiovasc J Afr; 2008; 19(3):152-4. PubMed ID: 18568176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bullous systemic lupus erythematosus responding to dapsone.
    Ludgate MW; Greig DE
    Australas J Dermatol; 2008 May; 49(2):91-3. PubMed ID: 18412808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis in ANCA-associated vasculitides.
    Pagnoux C; Chironi G; Simon A; Guillevin L
    Ann N Y Acad Sci; 2007 Jun; 1107():11-21. PubMed ID: 17804528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute lupus hemophagocytic syndrome].
    Nomura S; Fukuhara S
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):352-4. PubMed ID: 9851159
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid progression of atrioventricular nodal blockade in a patient with systemic lupus erythematosus.
    Makaryus JN; Catanzaro JN; Goldberg S; Makaryus AN
    Am J Emerg Med; 2008 Oct; 26(8):967.e5-7. PubMed ID: 18926371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atherosclerosis risk factors in systemic lupus erythematosus.
    Agarwal S; Elliott JR; Manzi S
    Curr Rheumatol Rep; 2009 Aug; 11(4):241-7. PubMed ID: 19691926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokines and cardiovascular risk.
    Aukrust P; Halvorsen B; Yndestad A; Ueland T; Øie E; Otterdal K; Gullestad L; Damås JK
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1909-19. PubMed ID: 18669888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.
    Full LE; Ruisanchez C; Monaco C
    Arthritis Res Ther; 2009; 11(2):217. PubMed ID: 19435478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
    Ayoub S; Hickey MJ; Morand EF
    Nat Clin Pract Rheumatol; 2008 Feb; 4(2):98-105. PubMed ID: 18235539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Premature coronary disease in systemic lupus.
    Violi F; Loffredo L; Ferro D
    N Engl J Med; 2004 Apr; 350(15):1571-5; author reply 1571-5. PubMed ID: 15074010
    [No Abstract]   [Full Text] [Related]  

  • 40. Accelerated cardiovascular disease in patients with lupus: a review.
    Seavy LM; Grosel JM
    JAAPA; 2012 Dec; 25(12):28-32. PubMed ID: 23600000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.